7141 POSTER Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)

✍ Scribed by Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; Bahl, A.; Tomczak, P.; Wagner, A.; Quinn, D.

• Book ID: 122824596
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 46 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72056-1